Leur histoire
Founded in 2019 by David del Bourgo, Julien Cottineau, and Lucia Cinque, WhiteLab Genomics combines computer science and biology to accelerate the development of genomic medicines. Our AI-powered technology analyzes complex biological data to significantly reduce development timelines and mitigate associated risks. Through in-silico simulations, we design optimized payloads and vectors.
We collaborate with leading pharmaceutical companies like Sanofi, top academic institutions, and innovative biotech firms to accelerate the delivery of life-saving therapies to the market.
Recognized for our contributions to advancing the field of gene and cell therapy, we're part of Y Combinator, the French Tech 2030 Program and have joined Bayer Co.Lab in Cambridge, MA, as well as Ginkgo Bioworks' Technology Network.
